**Core Concept**
Intracardiac defibrillators (ICDs) are implantable devices designed to prevent sudden cardiac death by delivering electric shocks to restore a normal heartbeat in individuals at high risk of life-threatening arrhythmias. This includes patients with specific structural heart diseases and those who have experienced a myocardial infarction with coronary artery disease.

**Why the Correct Answer is Right**
ICDs are particularly useful for patients with Brugada syndrome, a genetic disorder affecting the ion channels in the heart, which predisposes individuals to life-threatening arrhythmias. In arrhythmogenic right ventricular (RV) dysplasia, ICDs help manage the risk of sudden cardiac death due to ventricular tachycardia or fibrillation. Following an acute myocardial infarction (MI) with coronary artery disease (CAD), ICDs can prevent sudden cardiac death in patients at high risk of ventricular arrhythmias.

**Why Each Wrong Option is Incorrect**
**Option A:** While Brugada syndrome is a recognized indication for ICD implantation, option A is incomplete because ICDs are also beneficial for patients with other conditions not listed here.
**Option B:** Although arrhythmogenic RV dysplasia is a valid indication for ICD placement, option B is incorrect because it fails to acknowledge the broader range of conditions that benefit from ICD therapy.
**Option C:** Following an acute MI with CAD, ICDs are indeed useful for preventing sudden cardiac death, but option C is incomplete because it neglects the other indications for ICD placement.

**Clinical Pearl / High-Yield Fact**
ICDs are most effective in preventing sudden cardiac death when implanted in patients with a history of life-threatening arrhythmias or those with specific structural heart diseases, such as Brugada syndrome or arrhythmogenic RV dysplasia. This highlights the importance of accurate risk stratification and careful patient selection for ICD implantation.

**Correct Answer Line**
✓ Correct Answer: D. All of the above